Beta blockers as cardioprotective agents: Part II - Focus on prevention of sudden cardiac death

American Journal of Managed Care

Volumn 8, Issue 9 SUPPL., 2002, Pages 18-24

  Goldstein, Sidney ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; METOPROLOL; METOPROLOL SUCCINATE; PLACEBO; POTASSIUM; PROPRANOLOL; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG EFFICACY; DRUG RELEASE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAXIMUM TOLERATED DOSE; META ANALYSIS; MORTALITY; POPULATION RISK; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROBABILITY; REVIEW; SECONDARY PREVENTION; SUDDEN DEATH; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; HYPERTENSION; MALE; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036296736     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Sudden cardiac death in the United States, 1989 to 1998
2. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group
3. Task force on Sudden Cardiac Death of the European Society of Cardiology
4. Ambulatory sudden cardiac death: Mechanism of production of fatal arrhythmia on the basis of data from 157 cases
5. Diuretic agents versus beta blockers. Comparison of effects on mortality, stroke, and coronary events
6. Coronary artery disease can be prevented by antihypertensive therapy: Experiences from the MAPHY study
7. Metoprolol versus thiazide diuretics in hypertension: Morbidity results from the MAPHY study
8. Left ventricular hypertrophy as a risk factor: The Framingham experience
9. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death
10. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
11. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
12. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
13. Effect on mortality of metoprolol in acute myocardial infarction: A double-blind randomised trial
14. Effect of beta blockade on mortality among high-risk and low-risk patients after myocardial infarction
15. Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction
16. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
17. Beta blockers and sudden cardiac death
18. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for health care professionals from the American Heart Association and the American College of Cardiology
19. Left ventricular ejection fraction in the thrombolytic era remains a powerful predictor of long-term but not short-term all-cause, cardiac and arrhythmic mortality after myocardial infarction - A secondary meta-analysis of 2,828 patients
20. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
21. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: The CAPRICORN randomised trial
22. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
23. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). MERIT-HF Study Group
24. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial
25. Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction
26. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
27. Current role of beta-adrenergic blockers in the management of chronic heart failure
28. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group